Skip to content

Key Takeaways

  • The prospect of US interest-rate cuts continues to drive markets. The Federal Reserve (Fed), in its recent policy meeting, guided for three quarter-point rate cuts by the end of 2024.
  • Lower US and global interest rates—coupled with a likely US soft landing and moderating inflation—may bode well for selected markets, sectors and companies.
  • In North America rate cuts may catalyze further multiple expansion, but we are mindful of valuations. In Europe, we are keen on quality opportunities particularly in the United Kingdom, as well as undervalued small-cap stocks.
  • In Asia, we look to capture mispriced opportunities amid the volatility and low valuations in China and Hong Kong, as well as beneficiaries of Japan’s economic normalization.
  • Growth sectors with larger capital expenditures (capex), such as information technology and health care, may feel a lessened financial burden amid lower interest rates.

Fundamentals and valuations still matter

In our view, prudent stock selection and portfolio positioning remain critical as investors navigate the push-and-pull effects of lower interest rates. Despite impending rate cuts, interest rates are unlikely to return to the near-zero level during the COVID-19 pandemic. As such, companies with weak balance sheets should not be expected to see improved financial health and sustained earnings growth just on rate cuts alone. While the excitement over rate cuts may give certain stocks a short-term performance boost, stock selection based on bottom-up fundamentals—especially in terms of free cash flow generation and future earnings power—and valuations should continue to underpin investment decisions.



IMPORTANT LEGAL INFORMATION

Information on this website is intended to be of general information only and does not constitute investment or financial product advice. It expresses no views as to the suitability of the products or services described as to the individual circumstances, objectives, financial situation, or needs of any investor. You should conduct your own investigation or consult a financial adviser before making any decision to invest. Please read the relevant Product Disclosure Statements (PDSs), and any associated reference documents before making an investment decision.

Neither Franklin Templeton Australia, nor any other company within the Franklin Templeton group guarantees the performance of any Fund, nor do they provide any guarantee in respect of the repayment of your capital. In accordance with the Design and Distribution Obligations, we maintain Target Market Determinations (TMD) for each of our Funds. All documents can be found via the Literature Page or by calling 1800 673 776. 

CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.